New Key Statistics Module, Z-Score and F-Score
NAS:TCON Key Ratios
Market Cap $ M | 4.24 |
Enterprise Value $ M | -4.19 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 0.25 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 12.00 |
EPS (TTM) $ | -5.00 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -1.13 |
EV-to-EBITDA | -1.12 |
PEG | -- |
Shares Outstanding M | 2.28 |
Net Margin (%) | -29.79 |
Operating Margin % | -73.87 |
Pre-tax Margin (%) | -29.79 |
Quick Ratio | 0.89 |
Current Ratio | 0.89 |
ROA % (ttm) | -30.15 |
ROE % (ttm) | -- |
ROIC % (ttm) | -204.19 |
Dividend Yield % | -- |
Altman Z-Score | -30.82 |
TCON Number of Guru Trades
TCON Volume of Guru Trades
Gurus Latest Trades with NAS:TCON
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TCON is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TRACON Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:TCON
Total 0- 1